CORMORANT ASSET MANAGEMENT, LP – Akero Therapeutics, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$0
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+260.32%
quarter
Akero Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -403.78K shares | -3.81M | $34.05 | 0 |
| Q2 2022 | share | 0.00% | 0 shares | -1.91M | $9.45 | 403.78K | |
| Q1 2022 | share | 0.00% | 0 shares | -2.81M | $14.19 | 403.78K | |
| Q4 2021 | share | Decrease | -32.70% | -196.21K shares | -4.87M | $21.42 | 403.78K |
| Q3 2021 | share | 0.00% | 0 shares | -1.47M | $22.35 | 600K | |
| Q2 2021 | share | Decrease | -19.20% | -142.54K shares | -6.65M | $24.81 | 600K |
| Q1 2021 | share | 0.00% | 0 shares | 2.38M | $29.01 | 742.54K | |
| Q4 2020 | share | Decrease | -13.61% | -117.00K shares | -7.30M | $25.8 | 742.54K |
| Q3 2020 | share | Increase | +45.06% | 267.01K shares | 11.7M | $30.79 | 859.55K |
| Q2 2020 | share | Decrease | -7.78% | -50K shares | 1.14M | $24.92 | 592.53K |
| Q1 2020 | share | Decrease | -13.24% | -98.08K shares | -2.81M | $21.2 | 642.53K |
| Q4 2019 | share | 0.00% | 0 shares | -411K | $22.2 | 740.62K | |
| Q3 2019 | share | Decrease | -3.55% | -27.22K shares | 2.14M | $22.75 | 740.62K |
| Q2 2019 | share | Increase | 0.00% | 767.84K shares | 14.70M | $19.15 | 767.84K |